Securian Asset Management Inc. Lowers Position in Teleflex Incorporated (NYSE:TFX)

Securian Asset Management Inc. decreased its stake in shares of Teleflex Incorporated (NYSE:TFX) by 7.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,398 shares of the medical technology company’s stock after selling 200 shares during the period. Securian Asset Management Inc.’s holdings in Teleflex were worth $427,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Apollon Wealth Management LLC increased its holdings in Teleflex by 3.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock worth $377,000 after acquiring an additional 55 shares during the last quarter. HighTower Advisors LLC lifted its holdings in Teleflex by 1.7% during the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after purchasing an additional 66 shares during the last quarter. Huntington National Bank boosted its position in Teleflex by 32.5% during the third quarter. Huntington National Bank now owns 310 shares of the medical technology company’s stock worth $77,000 after purchasing an additional 76 shares during the period. Hengehold Capital Management LLC increased its stake in shares of Teleflex by 7.3% in the fourth quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock worth $229,000 after purchasing an additional 88 shares in the last quarter. Finally, Exchange Traded Concepts LLC raised its position in shares of Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after purchasing an additional 94 shares during the period. Institutional investors own 95.62% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on TFX. Raymond James lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Wells Fargo & Company cut their price target on Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a report on Friday, February 28th. Morgan Stanley decreased their price objective on Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 5th. Piper Sandler restated a “neutral” rating and issued a $140.00 target price (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Wednesday, March 12th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $182.63.

Teleflex Trading Up 1.4 %

Shares of TFX opened at $139.60 on Tuesday. Teleflex Incorporated has a 1-year low of $128.55 and a 1-year high of $249.91. The company has a market capitalization of $6.47 billion, a P/E ratio of 27.75, a P/E/G ratio of 1.73 and a beta of 1.21. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The firm’s 50 day simple moving average is $166.18 and its 200 day simple moving average is $196.64.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date was Friday, March 7th. Teleflex’s payout ratio is currently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.